U.S. Mortgage Finance Stock News

Aveanna Healthcare Holdings (AVAH) has put fresh earnings in focus after reporting first quarter results, with higher sales and net income than a year earlier and slightly raised full year revenue guidance. See our latest analysis for Aveanna Healthcare Holdings. At a share price of US$7.33, Aveanna has pulled back about 4% over the past week but is still up roughly 12% over 30 days. Its 1 year total shareholder return of about 38% and very large 3 year total shareholder return suggest...

In recent months, First Advantage reported Q1 2026 results showing 8.6% revenue growth, expanding margins, and a move from loss-making to positive earnings per share, followed by an analyst upgrade from Barclays citing stronger operational execution. An interesting aspect of this development is that these improvements arrived after a period of modest earnings expansion and declining free cash flow margins, suggesting a potential shift in how efficiently the company converts its market...

Event context and quick snapshot Texas Capital Bancshares (TCBI) has drawn investor attention after recent trading, with the stock last closing at US$99.39 and showing limited movement over the past month along with a stronger total return profile over the past 3 months and year. See our latest analysis for Texas Capital Bancshares. The recent 1-year total shareholder return of 39.12% and 3-year total shareholder return of 100.67% suggest momentum has been building. This contrasts with the...

In recent months, Citizens Financial Group reported mixed first-quarter results, with revenue roughly matching forecasts, slightly higher net interest income, but tangible book value per share coming in below analyst estimates amid a softer backdrop for regional banks. At the same time, its multiyear "Reimagine the Bank" program, targeting about US$450 million in run-rate efficiency gains, underscores management’s emphasis on reshaping operations and cost structure despite near-term...

Earlier in May 2026, Dynex Capital’s board declared a US$0.17 per-share cash dividend for May, payable on June 1, 2026, to shareholders of record as of May 21, 2026. At the same time, shareholders approved doubling the company’s authorized common shares to 720 million and backed board, compensation, and governance measures, signaling support for Dynex Capital’s evolving capital structure and leadership framework. We will now examine how the doubling of authorized common shares shapes Dynex...

Affirm Holdings (AFRM) is back in focus after announcing that its buy now, pay later options will roll out across Google Search, AI Mode, and the Gemini app via Google Pay checkout. See our latest analysis for Affirm Holdings. The news around Google integration comes as Affirm's share price shows mixed momentum, with a 36.24% 90 day share price return and a 32.29% 1 year total shareholder return, but a year to date share price decline of 11.90% from the latest close of US$65.22. If this kind...

Earlier in May 2026, FTI Consulting appointed Andreas P. Stöcklin to lead its Transactions practice across Continental Europe and named Emanuele Grasso as Senior Managing Director and head of the Corporate Finance segment in Italy, both joining the EMEA management structure to deepen M&A and transaction support capabilities. These hires bring decades of cross-border deal experience and board advisory expertise from firms such as Kroll and PwC, highlighting FTI Consulting’s intent to build...

In recent months, AngloGold Ashanti has faced increased scrutiny as ABSA Securities downgraded the miner, while insiders, including the CEO and a director, sold shares without any offsetting insider purchases. This combination of analyst caution on costs and operations alongside ongoing insider selling raises fresh questions about how management views the company’s current positioning. Now we’ll examine how ABSA’s downgrade, rooted in mining cost inflation and operational risk, may reshape...

Sun Communities (SUI) has drawn investor attention after recent share moves, with the stock up 1.2% over the past day and 5.1% over the past week, despite declines over the past month. See our latest analysis for Sun Communities. The recent 7 day share price return of 5.1% contrasts with more muted year to date gains of 4.6% and a 1 year total shareholder return of 10.2%. This suggests near term momentum is improving from a softer medium term trend. If this move in Sun Communities has you...

Illumina, Inc. has added former Labcorp Executive Chairman and CEO David P. King to its Board of Directors, following the May 21, 2026 annual shareholder meeting and alongside equity grants to several directors as part of their compensation. King’s deep background in large-scale diagnostics businesses and clinical operations underlines Illumina’s push to embed genomics more firmly into everyday medical decision-making as it refreshes its Board. We’ll now examine how King’s board appointment,...

Earlier in May 2026, BioMarin reported that its Phase 3 CANOPY-HCH-3 trial of VOXZOGO in children with hypochondroplasia met its primary endpoint, showing a statistically significant 2.33 cm/year gain in annualized growth velocity over placebo and meaningful improvements in arm span with a safety profile consistent with prior use in achondroplasia. Because hypochondroplasia currently has no approved therapies, these data and BioMarin’s plan to file a supplemental FDA application in the third...

How Balchem’s Recent Performance Frames the Story for Investors Balchem (BCPC) has been steady over the past day, but the stock is up about 1.4% over the past week and down roughly 7% over the past month, prompting closer investor attention. See our latest analysis for Balchem. That recent 7% one month share price pullback, alongside a 5.0% year to date share price gain and a 3 year total shareholder return of 34.3%, suggests momentum has cooled but long term holders have still been...

Recent share performance and context Oppenheimer Holdings (OPY) has seen mixed share performance recently, with the stock down about 3% over the past day and roughly 9% over the past month, yet up around 9% in the past 3 months. See our latest analysis for Oppenheimer Holdings. Despite the recent 9% decline in the 1 month share price return to US$93.86, momentum over the year still looks constructive. A 29.21% year to date share price return and a 50.07% 1 year total shareholder return...

In May 2026, MicroVision, Inc. reported first quarter 2026 results, with sales rising to US$935,000 from US$589,000 a year earlier, while net loss narrowed to US$25.29 million and basic loss per share improved to US$0.08 from US$0.12. This combination of higher sales and a smaller loss suggests incremental progress in MicroVision’s efforts to scale its lidar and perception technology business. We'll examine how this early revenue growth and reduced quarterly loss could influence...

Melco Resorts & Entertainment (MLCO) has been drawing attention after a period of weaker share performance, with the stock down over the past month and past 3 months. This has prompted closer scrutiny of its current valuation. See our latest analysis for Melco Resorts & Entertainment. At a latest share price of $5.38, Melco Resorts & Entertainment has seen its 7 day share price return fall 2.71% and its year to date share price return decline 28.36%, while the 5 year total shareholder return...

Why Post Holdings stock is on investors’ radar today Post Holdings (POST) is drawing attention after recent trading left the stock down over the past month and past 3 months, prompting investors to reassess its consumer packaged foods and foodservice footprint. At a recent close of US$97.17 and a market value of about US$4.4b, the company sits in the mid cap range for U.S. food and beverage stocks, with operations spanning cereals, pet food, refrigerated retail products, and foodservice...

Mirum Pharmaceuticals (MIRM) has just completed a zero coupon convertible note offering of $600 million due 2032, a financing move that can reshape its capital structure and influence how investors assess the stock. See our latest analysis for Mirum Pharmaceuticals. Mirum’s recent zero coupon convertible note offering comes after a mixed stretch for the stock, with the share price up 26.32% year to date but down 8.24% over 90 days. The one year total shareholder return of 124.14% and five...

Builders FirstSource previously filed a US$41.62 million shelf registration for 6,050,000 common shares tied to its ESOP and confirmed a planned leadership transition naming Mike Hiller as Chief Operating Officer-designate while appointing Coley O’Brien as Chief Human Resources Officer. This combination of an employee-focused share offering and a long-term succession plan underscores the company’s emphasis on workforce alignment and operational continuity. We’ll now examine how the COO...

Hub Group (HUBG) recently received a Nasdaq notice of non compliance after missing the filing deadline for its March 31, 2026 Form 10 Q, highlighting ongoing restatements and extended reporting uncertainty. See our latest analysis for Hub Group. The Nasdaq notice comes after Hub Group signaled delayed filings earlier in May, yet the stock has held relatively firm, with a 1-day share price return of 1.92%, a 7-day share price return of 8.62%, and a 1-year total shareholder return of 26.17%...

Event overview and recent share performance Open Text (NasdaqGS:OTEX) has drawn fresh attention after a period in which the stock is down about 26% year to date and down about 38% over the past 3 years, prompting investors to reassess the business. See our latest analysis for Open Text. Recent price action has been choppy, with a 1 month share price return of 4.73%, a year to date share price return that is down 26.06%, and a 3 year total shareholder return that is down 37.97%, signaling that...

Earlier this month, Driftwood Hospitality Management expanded its use of Flywire’s hospitality payments platform across nearly 90 U.S. hotel properties, digitizing contracts, deposits and multi-channel guest payments while cutting manual processing and fees, particularly through greater ACH adoption. This rollout shows how Flywire’s software-led payments model can reshape operational workflows for large hotel portfolios, pairing cost savings with a more seamless guest experience across major...

In May 2026, Inhibrx Biosciences reported a first-quarter net loss of US$33.44 million, narrower than a year earlier, and released positive interim Phase 2 data from its HexAgon trial of INBRX-106 plus pembrolizumab in first-line PD-L1 positive metastatic or unresectable recurrent head and neck squamous cell carcinoma. The interim data showed a higher confirmed objective response rate and the emergence of complete responses with the INBRX-106 combination, underscoring the potential...

Science Applications International (SAIC) has drawn fresh attention after its recent share performance, with the stock near US$100 and returns over the past 3 months outpacing its move over the past month. See our latest analysis for Science Applications International. At around US$100, the recent 3.99% 1 day and 14.19% 3 month share price returns suggest momentum has picked up again, even as the year to date share price return is slightly down and the 1 year total shareholder return has...

Recent stock move puts Old National Bancorp in focus Old National Bancorp (ONB) is back on investors’ radar after a recent share price move, with the stock last closing at US$23.94 and posting mixed short term returns across the past week and month. See our latest analysis for Old National Bancorp. That recent share price move sits within a steady trend, with a 1-year total shareholder return of 19.13% and a 3-year total shareholder return above 2x, suggesting momentum has been building over...